Micro- and nanoparticulates for DNA vaccine delivery

Experimental Biology and Medicine

Volumn 241, Issue 9, 2016, Pages 919-929

  Farris, Eric ^a   Brown, Deborah M ^a,b   Ramer Tait, Amanda E ^a   Pannier, Angela K ^a,c  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

biomaterials; DNA vaccine; oral delivery; transfection; vaccination

Indexed keywords

ALGINIC ACID; CATIONIC SOLID LIPID NANOPARTICLE; CHITOSAN; CHITOSAN NANOPARTICLE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INORGANIC COMPOUND; INTERLEUKIN 21; INTERLEUKIN 4; LIPOSOME; MACROGOL; NANOPARTICLE; POLYCAPROLACTONE; POLYETHYLENEIMINE; POLYGLACTIN; POLYMER; QUANTUM DOT; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; ZEIN; LIPID;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE EPITHELIUM; LYMPHOCYTE PROLIFERATION; MICRONEEDLE; MUCOSAL IMMUNITY; NANOENCAPSULATION; NONHUMAN; PATIENT COMPLIANCE; T LYMPHOCYTE ACTIVATION; TRANSDERMAL DRUG DELIVERY SYSTEM; VIRUS LIKE AGENT; ANIMAL; CHEMISTRY; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PROCEDURES;

ADMINISTRATION, ORAL; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INFUSIONS, PARENTERAL; LIPIDS; LIPOSOMES; NANOPARTICLES; POLYMERS; VACCINES, DNA;

EID: 84971612325     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370216643771     Document Type: Article

References (93)

1. A.A.WaltersC.KrastevA.V.S.HillA.Milicic. Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy. J Pharm Pharmacol2015; 67: 400–8.
2. S.H.KimK.Y.LeeY.S.Jang. Mucosal immune system and M cell-targeting strategies for oral mucosal vaccination. Immune Netw2012; 12: 165–75.
3. D.N.NguyenJ.J.GreenJ.M.ChanR.LangerD.G.Anderson. Polymeric materials for gene delivery and DNA vaccination. Adv Mater2009; 21: 847–67.
4. J.O.JosefsbergB.Buckland. Vaccine process technology. Biotechnol Bioeng2012; 109: 1443–60.
5. O.S.KumruS.B.JoshiD.E.SmithC.R.MiddaughT.PrusikD.B.Volkin. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals2014; 42: 237–59.
6. B.LangerM.RennerJ.SchererS.SchüleK.CichutekSafety assessment of biolistic DNA vaccination. In: (eds). Biolistic DNA delivery, New York: Humana Press, 2013, pp. 371–88.
7. M.A.Liu. DNA vaccines: an historical perspective and view to the future. Immunol Rev2011; 239: 62–84.
8. R.P.DeeringS.KommareddyJ.B.UlmerL.A.BritoA.J.Geall. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opin Drug Deliv2014; 11: 885–99.
9. M.A.KutzlerD.B.Weiner. DNA vaccines: ready for prime time?Nat Rev Genet2008; 9: 776–88.
10. A.StachyraA.Gora-SochackaA.Sirko. DNA vaccines against influenza. Acta Biochim Pol2014; 61: 515–22.
11. M.IngolottiO.KawalekarD.J.ShedlockK.MuthumaniD.B.Weiner. DNA vaccines for targeting bacterial infections. Expert Rev Vaccines2010; 9: 747–63.
12. J.A.CarvalhoJ.RodgersJ.AtouguiaD.M.PrazeresG.A.Monteiro. DNA vaccines: a rational design against parasitic diseases. Expert Rev Vaccines2010; 9: 175–91.
13. R.J.AndersonJ.Schneider. Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Vaccine2007; 25(Suppl 2): B24–34.
14. P.van der BruggenC.TraversariP.ChomezC.LurquinE.De PlaenB.Van den EyndeA.KnuthT.Boon. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science1991; 254: 1643–7.
15. B.YangJ.JeangA.YangT.C.WuC.F.Hung. DNA vaccine for cancer immunotherapy. Hum Vaccines Immunother2014; 10: 3153–64.
16. D.T.O'HaganM.SinghJ.B.Ulmer. Microparticles for the delivery of DNA vaccines. Immunol Rev2004; 199: 191–200.
17. S.PrabhaW.-Z.ZhouJ.PanyamV.Labhasetwar. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm2002; 244: 105–15.
18. K.ChenA.Cerutti. Vaccination strategies to promote mucosal antibody responses. Immunity2010; 33: 479–91.
19. D.T.PageS.Cudmore. Innovations in oral gene delivery: challenges and potentials. Drug Discov Today2001; 6: 92–101.
20. M.R.NeutraP.A.Kozlowski. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol2006; 6: 148–58.
21. H.KiyonoS.Fukuyama. NALT versus PEYER'S-patch-mediated mucosal immunity. Nat Rev Immunol2004; 4: 699–710.
22. C.M.BarbonL.BakerC.LajoieU.RamstedtM.L.HedleyT.M.Luby. In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization. Vaccine2010; 28: 7852–64.
23. K.ZhaoG.X.LiY.Y.JinH.X.WeiQ.S.SunT.T.HuangY.F.WangG.Z.Tong. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres. J Microencapsul2010; 27: 178–86.
24. S.GaoN.ZhaoS.AmerM.QianM.LvY.ZhaoX.SuJ.CaoH.HeB.Zhao. Protective efficacy of PLGA microspheres loaded with divalent DNA vaccine encoding the OmpA gene of Aeromonas veronii and the hly gene of Aeromonas hydrophila in mice. Vaccine2013; 31: 5754–9.
25. A.EratalayF.F.Coskun-AriF.OnerE.Ozcengiz. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and interleukin-2. J Microencapsul2010; 27: 48–56.
26. M.MatijevicM.L.HedleyR.G.UrbanR.M.ChiczC.LajoieT.M.Luby. Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11. Cell Immunol2011; 270: 62–9.
27. M.SinghM.BrionesG.OttD.O'Hagan. Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA2000; 97: 811–6.
28. K.S.ReddyB.R.RashmiH.J.DechammaS.GopalakrishnaN.BanumathiV.V.S.SuryanarayanaG.R.Reddy. Cationic microparticle poly(d,l-lactide-co-glycolide)-coated DNA vaccination induces a long-term immune response against foot and mouth disease in guinea pigs. J Gene Med2012; 14: 348–52.
29. P.W.LeeS.H.HsuJ.S.TsaiF.R.ChenP.J.HuangC.J.KeZ.X.LiaoC.W.HsiaoH.J.LinH.W.Sung. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials2010; 31: 2425–34.
30. M.N.ShuaibuM.S.CherifT.KurosakiG.K.HelegbeM.KikuchiT.YanagiH.SasakiK.Hirayama. Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal. Vaccine2011; 29: 3239–47.
31. M.J.GoldF.AntignanoM.R.HughesC.ZaphK.M.McNagny. Dendritic-cell expression of Ship1 regulates Th2 immunity to helminth infection in mice. Eur J Immunol2015; 46: 122–30.
32. T.UtoM.ToyamaY.NishiT.AkagiF.ShimaM.AkashiM.Baba. Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo. Results Immunol2013; 3: 1–9.
33. M.Koping-HoggardI.TubulekasH.GuanK.EdwardsM.NilssonK.M.VarumP.Artursson. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther2001; 8: 1108–21.
34. N.CsabaM.Koping-HoggardM.J.Alonso. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int J Pharm2009; 382: 205–14.
35. W.G.LiuX.ZhangS.J.SunG.J.SunK.D.YaoD.C.LiangG.GuoJ.Y.Zhang. N-alkylated chitosan as a potential nonviral vector for gene transfection. Bioconjug Chem2003; 14: 782–9.
36. D.LeeR.LockeyS.Mohapatra. Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans. J Nanosci Nanotechnol2006; 6: 2860–6.
37. H.D.LuH.Q.ZhaoK.WangL.L.Lv. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Int J Pharm2011; 420: 358–65.
38. J.ZhangC.TangC.Yin. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages. Biomaterials2013; 34: 3667–77.
39. C.L.BueterC.K.LeeV.A.K.RathinamG.J.HealyC.H.TaronC.A.SpechtS.M.Levitz. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J Biol Chem2011; 286: 35447–55.
40. S.UmthongA.BuaklinA.JacquetN.SangjunR.KerdkaewK.PatarakulT.Palaga. Immunogenicity of a DNA and recombinant protein vaccine combining LipL32 and Loa22 for leptospirosis using chitosan as a delivery system. J Microbiol Biotechnol2015; 25: 526–36.
41. D.F.ChaiY.YueW.XuC.S.DongS.D.Xiong. Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis. Hum Vaccines Immunother2014; 10: 1284–94.
42. W.XuY.ShenZ.G.JiangY.WangY.W.ChuS.D.Xiong. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection. Vaccine2004; 22: 3603–12.
43. C.SawaengsakY.MoriK.YamanishiP.SrimanoteW.ChaicumpaA.MitrevejN.Sinchaipanid. Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes. Int J Pharma2014; 473: 113–25.
44. A.TahamtanA.GhaemiA.GorjiH.R.KalhorA.SajadianA.TabarraeiA.MoradiF.AtyabiM.Kelishadi. Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. J Biomed Sci2014; 21: 10–10.
45. K.ZhaoX.M.ShiY.ZhaoH.X.WeiQ.S.SunT.T.HuangX.Y.ZhangY.F.Wang. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine2011; 29: 8549–56.
46. R.K.NandaI.A.HajamB.M.EdaoK.RamyaM.RajangamS.C.SekarK.GaneshV.BhanuprakashS.Kishore. Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs. Biologicals2014; 42: 153–9.
47. Y.X.PengW.J.YaoB.WangL.Zong. Mannosylated chitosan nanoparticles based macrophage-targeting gene delivery system enhanced cellular uptake and improved transfection efficiency. J Nanosci Nanotechnol2015; 15: 2619–27.
48. W.J.YaoY.X.PengM.Z.DuJ.LuoL.Zong. Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity. Mol Pharm2013; 10: 2904–14.
49. B.LayekL.LippJ.Singh. APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine. J Control Release2015; 207: 143–53.
50. P.L.FelgnerT.R.GadekM.HolmR.RomanH.W.ChanM.WenzJ.P.NorthropG.M.RingoldM.Danielsen. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA1987; 84: 7413–7.
51. C.LonezM.BessodesD.SchermanM.VandenbrandenV.EscriouJ.-M.Ruysschaert. Cationic lipid nanocarriers activate toll-like receptor 2 and NLRP3 inflammasome pathways. Nanomedicine2014; 10: 775–82.
52. R.SrinivasA.GaruG.MokuS.B.AgawaneA.Chaudhuri. A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups. Biomaterials2012; 33: 6220–9.
53. F.PercheT.BenvegnuM.BerchelL.LebegueC.PichonP.A.JaffresP.Midoux. Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA. Nanomedicine2011; 7: 445–53.
54. J.WangR.R.ZhuB.GaoB.WuK.LiX.Y.SunH.LiuS.L.Wang. The enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvant. Biomaterials2014; 35: 466–78.
55. A.LiL.QinW.WangR.ZhuY.YuH.LiuS.Wang. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response. Biomaterials2011; 32: 469–77.
56. D.DoroudF.ZahedifardA.VatanaraA.R.NajafabadiY.TaslimiR.VahabpourF.TorkashvandB.VaziriS.Rafati. Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection. J Control Release2011; 153: 154–62.
57. D.P.VangasseriZ.CuiW.ChenD.A.HokeyL.D.FaloJrL.Huang. Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol2006; 23: 385–95.
58. N.W.KimM.S.LeeK.R.KimJ.E.LeeK.LeeJ.S.ParkY.MatsumotoD.G.JoH.LeeD.S.LeeJ.H.Jeong. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine. J Control Release2014; 179: 11–7.
59. Y.C.KimD.G.YooR.W.CompansS.M.KangM.R.Prausnitz. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. J Control Release2013; 172: 579–88.
60. R.C.KinesV.ZarnitsynT.R.JohnsonY.Y.S.PangK.S.CorbettJ.D.NicewongerA.GangopadhyayM.ChenJ.LiuM.R.PrausnitzJ.T.SchillerB.S.Graham. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. Plos One2015; 10: e0120797–e0120797.
61. G.M.GlennR.T.KenneyL.R.EllingsworthS.A.FrechS.A.HammondJ.P.Zoeteweij. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines2003; 2: 253–67.
62. X.HongL.WeiF.WuZ.WuL.ChenZ.LiuW.Yuan. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine. Drug Des Devel Ther2013; 7: 945–52.
63. Y.HuB.XuJ.XuD.ShouE.LiuJ.GaoW.LiangY.Huang. Microneedle-assisted dendritic cell-targeted nanoparticles for transcutaneous DNA immunization. Polym Chem2015; 6: 373–9.
64. P.C.DeMuthY.J.MinB.HuangJ.A.KramerA.D.MillerD.H.BarouchP.T.HammondD.J.Irvine. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater2013; 12: 367–76.
65. M.M.Levine. IDEAL” vaccines for resource poor settings. Vaccine2011; 29(Suppl 4): D116–25.
66. M.J.O'NeillL.BourreS.MelgarC.M.O'Driscoll. Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models. Drug Discov Today2011; 16: 203–18.
67. M.Bivas-BenitaM.LaloupS.VersteyheJ.DewitJ.D.BraekeleerE.JongertG.Borchard. Generation of toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int J Pharma2003; 266: 17–27.
68. D.H.JonesS.CorrisS.McDonaldJ.C.S.CleggG.H.Farrar. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine1997; 15: 814–7.
69. D.A.WangJ.XuY.H.FengY.LiuS.S.S.McHengaF.P.ShanJ.SasakiC.L.Lu. Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response. Vaccine2010; 28: 3134–42.
70. S.JainP.SinghV.MishraS.P.Vyas. Mannosylated niosomes as adjuvant–carrier system for oral genetic immunization against Hepatitis B. Immunol Lett2005; 101: 41–9.
71. M.L.ForrestJ.T.KoerberD.W.Pack. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem2003; 14: 934–40.
72. D.M.LynnR.Langer. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc2000; 122: 10761–8.
73. M.KurisawaM.YokoyamaT.Okano. Gene expression control by temperature with thermo-responsive polymeric gene carriers. J Control Release2000; 69: 127–37.
74. J.BeloorS.RamakrishnaK.NamC.S.ChoiJ.KimS.H.KimH.J.ChoH.ShinH.KimS.W.KimS.K.LeeP.Kumar. Effective gene delivery into human stem cells with a cell-targeting peptide-modified bioreducible polymer. Small2015; 11: 2069–79.
75. M.HashidaS.TakemuraM.NishikawaY.Takakura. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). J Control Release1998; 53: 301–10.
76. G.S.AsthanaA.AsthanaD.V.KohliS.P.Vyas. Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting. Biomed Res Int2014; 17: 526391.–526391.
77. A.R.DudhaniS.L.Kosaraju. Bioadhesive chitosan nanoparticles: preparation and characterization. Carbohydr Polym2010; 81: 243–51.
78. A.M.M.SadeghiF.A.DorkooshM.R.AvadiM.WeinholdA.BayatF.DelieR.GurnyB.LarijaniM.Rafiee-TehraniH.E.Junginger. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharma Biopharma2008; 70: 270–8.
79. H.L.JiangM.L.KangJ.S.QuanS.G.KangT.AkaikeH.S.YooC.S.Cho. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials2008; 29: 1931–9.
80. T.H.KimH.JinH.W.KimM.H.ChoC.S.Cho. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther2006; 5: 1723–32.
81. C.R.OliveiraC.M.F.RezendeM.R.SilvaO.M.BorgesA.P.PegoA.M.Goes. Oral vaccination based on DNA-chitosan nanoparticles against Schistosoma mansoni infection. Sci World J2012; 11: 938457–938457.
82. T.YeY.YueX.M.FanC.S.DongW.XuS.D.Xiong. M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine. Vaccine2014; 32: 4457–65.
83. M.D.BhavsarM.M.Amiji. Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract. AAPS PharmSciTech2008; 9: 288–94.
84. T.BhowmikB.D'SouzaM.N.UddinM.J.D'Souza. Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen. J Drug Target2012; 20: 364–71.
85. S.ChannarongW.ChaicumpaN.SinchaipanidA.Mitrevej. Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: the improvement of Peyer's patch targeting using a polyplex-loaded liposomes. AAPS PharmSciTech2011; 12: 192–200.
86. Z.LiuD.LvS.LiuJ.B.GongD.WangM.XiongX.N.ChenR.XiangX.Y.Tan. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice. Plos One2013; 8: 11–11.
87. S.K.MehtaG.KaurA.Verma. Fabrication of plant protein microspheres for encapsulation, stabilization and in vitro release of multiple anti-tuberculosis drugs. Colloids Surf A Physicochem Eng Asp2011; 375: 219–30.
88. Y.ZhangY.NiuY.LuoM.GeT.YangL.YuQ.Wang. Fabrication, characterization and antimicrobial activities of thymol-loaded zein nanoparticles stabilized by sodium caseinate–chitosan hydrochloride double layers. Food Chem2014; 142: 269–75.
89. H.-J.WangZ.-X.LinX.-M.LiuS.-Y.ShengJ.-Y.Wang. Heparin-loaded zein microsphere film and hemocompatibility. J Control Release2005; 105: 120–31.
90. Y.LuoZ.TengQ.Wang. Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3. J Agric Food Chem2012; 60: 836–43.
91. N.ParrisP.H.CookeK.B.Hicks. Encapsulation of essential oils in zein nanospherical particles. J Agric Food Chem2005; 53: 4788–92.
92. X.LiuQ.SunH.WangL.ZhangJ.-Y.Wang. Microspheres of corn protein, zein, for an ivermectin drug delivery system. Biomaterials2005; 26: 109–15.
93. M.C.RegierJ.D.TaylorT.BorcykY.YangA.K.Pannier. Fabrication and characterization of DNA-loaded zein nanospheres. J Nanobiotechnol2012; 10: 44–44.